Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT)

Neurooncol Adv. 2022 Jun 7;4(1):vdac090. doi: 10.1093/noajnl/vdac090. eCollection 2022 Jan-Dec.

¹ Department of Pediatrics and Child Health, University of Manitoba, Manitoba, Canada.
² Department of Pharmacy, Cancer Care Manitoba, Manitoba, Canada.
³ Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
⁴ Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
⁵ Department of Pediatric Hematology & Oncology, Cancer Care Manitoba, Manitoba, Canada.

No abstract available

Keywords: ATRT; Alisertib; Aurora kinase A; monotherapy; relapsed.